Paper36911797
Human CD8+ T-Cell Populations That Express Natural Killer Receptors.
Koh JY and 3 others. Immune Netw, 2023. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human CD8+ T-Cell Populations That Express Natural Killer Receptors. Papers, record 36911797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911797
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,433,347 | Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects. | Immunology | 2014 | https://conductscience.org/library/papers/24433347 | PubMed |
| 2 | 10,438,977 | The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. | J Immunol | 1999 | https://conductscience.org/library/papers/10438977 | PubMed |
| 3 | 30,503,208 | NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines. | Cell | 2018 | https://conductscience.org/library/papers/30503208 | PubMed |
| 4 | 28,767,726 | High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults. | PLoS One | 2017 | https://conductscience.org/library/papers/28767726 | PubMed |
| 5 | 15,940,674 | The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. | Eur J Immunol | 2005 | https://conductscience.org/library/papers/15940674 | PubMed |
| 6 | 33,893,172 | Natural killer cell receptors regulate responses of HLA-E-restricted T cells. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33893172 | PubMed |
| 7 | 20,132,973 | CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. | J Allergy Clin Immunol | 2010 | https://conductscience.org/library/papers/20132973 | PubMed |
| 8 | 8,892,619 | Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. | J Immunol | 1996 | https://conductscience.org/library/papers/8892619 | PubMed |
| 9 | 893,446 | Adhesion among neural cells of the chick embryo. II. Purification and characterization of a cell adhesion molecule from neural retina. | J Biol Chem | 1977 | https://conductscience.org/library/papers/893446 | PubMed |
| 10 | 11,323,697 | Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. | Nat Immunol | 2001 | https://conductscience.org/library/papers/11323697 | PubMed |
| 11 | 15,517,612 | Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes. | Eur J Immunol | 2004 | https://conductscience.org/library/papers/15517612 | PubMed |
| 12 | 33,664,730 | Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral Blood. | Front Immunol | 2020 | https://conductscience.org/library/papers/33664730 | PubMed |
| 13 | 36,099,881 | NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. | Cancer Cell | 2022 | https://conductscience.org/library/papers/36099881 | PubMed |
| 14 | 19,085,952 | CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. | Hepatology | 2009 | https://conductscience.org/library/papers/19085952 | PubMed |
| 15 | 30,503,213 | Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. | Cell | 2018 | https://conductscience.org/library/papers/30503213 | PubMed |
| 16 | 9,486,650 | HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. | Nature | 1998 | https://conductscience.org/library/papers/9486650 | PubMed |
| 17 | 18,579,582 | Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection. | J Virol | 2008 | https://conductscience.org/library/papers/18579582 | PubMed |
| 18 | 35,370,095 | Antigen presentation by MHC-E: a putative target for vaccination? | Trends Immunol | 2022 | https://conductscience.org/library/papers/35370095 | PubMed |
| 19 | 16,882,169 | Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis. | Br J Dermatol | 2006 | https://conductscience.org/library/papers/16882169 | PubMed |
| 20 | 10,537,110 | Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. | Nature | 1999 | https://conductscience.org/library/papers/10537110 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,827,837 | CD57-Expressing Lymphocytes: From Chronic Viral Response to Age-Related Inflammation. | Cells | 2026 | https://conductscience.org/library/papers/41827837 | PubMed |
| 41,704,679 | Phenotypic and functional heterogeneity of naïve CD8+ T cells in human peripheral blood during aging. | Front Aging | 2026 | https://conductscience.org/library/papers/41704679 | PubMed |
| 41,315,764 | Innate immunity in tumour immunoediting and immunosurveillance. | EMBO J | 2026 | https://conductscience.org/library/papers/41315764 | PubMed |
| 40,948,803 | Leveraging innate immune signals in CD8+ T cells to boost antitumor immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/40948803 | PubMed |
| 40,837,586 | Heterogeneity of CD8αα intraepithelial lymphocytes is transcriptionally conserved between TCRαβ and TCRγδ cell lineages. | Front Immunol | 2025 | https://conductscience.org/library/papers/40837586 | PubMed |
| 40,216,888 | The diversity of CD8+ T cell dysfunction in cancer and viral infection. | Nat Rev Immunol | 2025 | https://conductscience.org/library/papers/40216888 | PubMed |
| 40,144,851 | T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates. | JHLT Open | 2025 | https://conductscience.org/library/papers/40144851 | PubMed |
| 40,078,788 | Metabolic Signaling as a Driver of T Cell Aging. | Immune Netw | 2025 | https://conductscience.org/library/papers/40078788 | PubMed |
| 39,858,511 | A New Antibody-Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia. | Biomolecules | 2025 | https://conductscience.org/library/papers/39858511 | PubMed |
| 39,660,897 | Polycytotoxic T cells mediate antimicrobial activity against intracellular Mycobacterium tuberculosis. | Infect Immun | 2025 | https://conductscience.org/library/papers/39660897 | PubMed |
| 39,609,626 | Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma. | Nat Immunol | 2025 | https://conductscience.org/library/papers/39609626 | PubMed |
| 39,531,313 | In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functions. | J Clin Invest | 2024 | https://conductscience.org/library/papers/39531313 | PubMed |
| 38,455,459 | IL-15 in T-Cell Responses and Immunopathogenesis. | Immune Netw | 2024 | https://conductscience.org/library/papers/38455459 | PubMed |
| 38,397,909 | Cell States and Interactions of CD8 T Cells and Disease-Enriched Microglia in Human Brains with Alzheimer's Disease. | Biomedicines | 2024 | https://conductscience.org/library/papers/38397909 | PubMed |
| 38,250,325 | The role of natural killer T cells in liver transplantation. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/38250325 | PubMed |
| 37,907,738 | CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37907738 | PubMed |
| 37,317,967 | Negativity begets longevity in T cells. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37317967 | PubMed |
| 37,298,547 | Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298547 | PubMed |
| 36,911,804 | Back to the T Cell: Basic and Clinical Application. | Immune Netw | 2023 | https://conductscience.org/library/papers/36911804 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36911797
GET https://conductscience.org/api/papers/v1/36911797/references?page=2